Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:23 pm Purchase | 2024-12-31 | 13G | Catheter Precision, Inc. VTAK | Armistice Capital, LLC | 46,004 9.990% | 40,439 (+726.61%) | Filing History |
| 2025-02-14 5:23 pm Purchase | 2024-12-31 | 13G | VolitionRx Limited VNRX | Armistice Capital, LLC | 9,343,265 9.990% | 119,885 (+1.30%) | Filing History |
| 2025-02-14 5:22 pm Purchase | 2024-12-31 | 13G | Vincerx Pharma, Inc. VINC | Armistice Capital, LLC | 4,475,121 9.990% | 4,475,121 (New Position) | Filing History |
| 2025-02-14 5:22 pm Sale | 2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Armistice Capital, LLC | 7,358,000 9.620% | -290,000 (-3.79%) | Filing History |
| 2025-02-14 5:21 pm Purchase | 2024-12-31 | 13G | Treace Medical Concepts, Inc. TMCI | Armistice Capital, LLC | 6,209,000 9.970% | 13,000 (+0.21%) | Filing History |
| 2025-02-14 5:21 pm Purchase | 2024-12-31 | 13G | 60 Degrees Pharmaceuticals, Inc. SXTP | Armistice Capital, LLC | 95,373 9.990% | 56,121 (+142.97%) | Filing History |
| 2025-02-14 5:20 pm Sale | 2024-12-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN | Armistice Capital, LLC | 4,836,000 8.760% | -260,000 (-5.10%) | Filing History |
| 2025-02-14 5:20 pm Purchase | 2024-12-31 | 13G | Steakholder Foods Ltd. STKH | Armistice Capital, LLC | 8,662 9.990% | 490 (+5.99%) | Filing History |
| 2025-02-14 5:19 pm Unchanged | 2024-12-31 | 13G | Sadot Group Inc. SDOT | Armistice Capital, LLC | 41,152 6.560% | 0 (Unchanged) | Filing History |
| 2025-02-14 5:19 pm Sale | 2024-12-31 | 13G | Rockwell Medical, Inc. RMTI | Armistice Capital, LLC | 3,249,178 9.990% | -332,347 (-9.28%) | Filing History |
| 2025-02-14 5:18 pm Sale | 2024-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Armistice Capital, LLC | 1,152,000 6.540% | -384,000 (-25.00%) | Filing History |
| 2025-02-14 5:18 pm Sale | 2024-12-31 | 13G | PTC Therapeutics, Inc. PTCT | Armistice Capital, LLC | 6,378,000 8.270% | -856,898 (-11.84%) | Filing History |
| 2025-02-14 5:17 pm Sale | 2024-12-31 | 13G | ProMIS Neurosciences, Inc. PMN | Armistice Capital, LLC | 100,399 7.680% | -6,401 (-5.99%) | Filing History |
| 2025-02-14 5:17 pm Purchase | 2024-12-31 | 13G | Palisade Bio, Inc. PALI | Armistice Capital, LLC | 285,417 9.990% | 159,725 (+127.08%) | Filing History |
| 2025-02-14 5:15 pm Purchase | 2024-12-31 | 13G | Organovo Holdings, Inc. ONVO | Armistice Capital, LLC | 141,724 9.990% | 20,053 (+16.48%) | Filing History |
| 2025-02-14 5:15 pm Sale | 2024-12-31 | 13G | Orthofix Medical Inc. OFIX | Armistice Capital, LLC | 3,000,000 7.850% | -768,000 (-20.38%) | Filing History |
| 2025-02-14 5:14 pm Purchase | 2024-12-31 | 13G | Nevro Corp. NVRO | Armistice Capital, LLC | 3,736,000 9.970% | 8,000 (+0.21%) | Filing History |
| 2025-02-14 5:13 pm Purchase | 2024-12-31 | 13G | NanoVibronix, Inc. NAOV | Armistice Capital, LLC | 3,175 9.990% | 388 (+13.91%) | Filing History |
| 2025-02-14 5:11 pm Unchanged | 2024-12-31 | 13G | Mural Oncology plc MURA | Armistice Capital, LLC | 1,700,000 9.960% | 0 (Unchanged) | Filing History |
| 2025-02-14 5:08 pm Sale | 2024-12-31 | 13G | ASPIRA WOMENS HEALTH INC N AWHL | Armistice Capital, LLC | 800,797 4.990% | -455,203 (-36.24%) | Filing History |